Impact of BRAF mutations on clinical outcomes following liver surgery for colorectal liver metastases: An updated meta-analysis
- 1 November 2021
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 47 (11) , 2722-2733
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2013
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal CancerNew England Journal of Medicine, 2013
- Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutationInternational Journal of Cancer, 2011
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerBritish Journal of Cancer, 2011
- Mutations of KRAS and BRAF in Primary and Matched Metastatic Sites of Colorectal CancerJournal of Clinical Oncology, 2008
- Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 2008
- Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective StudyAnnals of Surgical Oncology, 2006
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002